| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BWAYBrainsWay Ltd. | 452.42M | 23.10 | 128.33 | 29.04% | 12.73% | 8.92% | 1.44% | 0.09 |
| INSPInspire Medical Systems, Inc. | 2.8B | 96.47 | 55.13 | 28.49% | 5.05% | 6.69% | 3.25% | 0.05 |
| TIVCTivic Health Systems, Inc. | 3.11M | 1.23 | -0.06 | -33.67% | -15.57% | -134.25% | ||
| COCHEnvoy Medical, Inc. | 19.42M | 0.67 | -0.45 | -28.8% | -104.75% | |||
| HSDTSolana Company | 128.03M | 3.10 | -0.72 | -19.25% | -393.59% | -6.89% | 0.01 | |
| NXLNexalin Technology, Inc. | 12.87M | 0.69 | -0.83 | 52.35% | -55.3% | -182.01% | ||
| CVRXCVRx, Inc. | 143.37M | 5.47 | -2.06 | 30.53% | -92.95% | -108.26% | 0.71 | |
| VANIVivani Medical, Inc. | 91.92M | 1.26 | -2.93 | -19.88% | 1.10 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 254.14K | 811.46K | 992.95K | 2.39M | 3.5M | 5.45M | 8.59M | 16.03M | 25.18M |
| Revenue Growth % | - | 2.19% | 0.22% | 1.41% | 0.46% | 0.56% | 0.58% | 0.87% | 0.57% |
| Cost of Goods Sold | 123.73K | 518.53K | 578.74K | 1.16M | 1.74M | 1.39M | 1.62M | 2.8M | 3.79M |
| COGS % of Revenue | 0.49% | 0.64% | 0.58% | 0.48% | 0.5% | 0.25% | 0.19% | 0.17% | 0.15% |
| Gross Profit | 130.41K | 292.93K | 414.21K | 1.23M | 1.76M | 4.07M | 6.98M | 13.23M | 21.4M |
| Gross Margin % | 0.51% | 0.36% | 0.42% | 0.52% | 0.5% | 0.75% | 0.81% | 0.83% | 0.85% |
| Gross Profit Growth % | - | 1.25% | 0.41% | 1.98% | 0.43% | 1.31% | 0.72% | 0.9% | 0.62% |
| Operating Expenses | 15.14M | 25.94M | 54.97M | 47.32M | 26.51M | 24.11M | 29.85M | 32.03M | 33.56M |
| OpEx % of Revenue | 59.58% | 31.96% | 55.36% | 19.8% | 7.58% | 4.42% | 3.47% | 2% | 1.33% |
| Selling, General & Admin | 7.17M | 18.11M | 42.5M | 35.42M | 21.84M | 21.57M | 24.33M | 26.71M | 31.2M |
| SG&A % of Revenue | 28.21% | 22.31% | 42.8% | 14.82% | 6.25% | 3.96% | 2.83% | 1.67% | 1.24% |
| Research & Development | 7.97M | 7.83M | 12.47M | 9.9M | 4.2M | 2.54M | 5.52M | 5.32M | 2.36M |
| R&D % of Revenue | 31.37% | 9.65% | 12.55% | 4.14% | 1.2% | 0.47% | 0.64% | 0.33% | 0.09% |
| Other Operating Expenses | 0 | -4.88K | -344.91K | 2M | 464.61K | 0 | 0 | 0 | 0 |
| Operating Income | -15.01M | -25.64M | -54.55M | -46.09M | -24.75M | -20.04M | -22.87M | -18.8M | -12.16M |
| Operating Margin % | -59.06% | -31.6% | -54.94% | -19.28% | -7.08% | -3.68% | -2.66% | -1.17% | -0.48% |
| Operating Income Growth % | - | -0.71% | -1.13% | 0.16% | 0.46% | 0.19% | -0.14% | 0.18% | 0.35% |
| EBITDA | -14.96M | -25.61M | -54.49M | -45.84M | -24.35M | -19.66M | -22.28M | -17.55M | -10.9M |
| EBITDA Margin % | -58.85% | -31.56% | -54.87% | -19.18% | -6.97% | -3.61% | -2.59% | -1.09% | -0.43% |
| EBITDA Growth % | - | -0.71% | -1.13% | 0.16% | 0.47% | 0.19% | -0.13% | 0.21% | 0.38% |
| D&A (Non-Cash Add-back) | 53.42K | 32.31K | 66.66K | 249.58K | 399.24K | 382K | 596K | 1.26M | 1.26M |
| EBIT | -15.01M | -28.91M | -54.55M | -44.09M | -24.28M | -20.04M | -22.87M | -19.02M | -12.16M |
| Net Interest Income | -771.25K | -7.02M | 1.01M | 970.59K | 84.33K | 11K | 287K | 433K | 572K |
| Interest Income | 0 | 99.03K | 1.01M | 970.59K | 84.33K | 11K | 287K | 433K | 572K |
| Interest Expense | 771.25K | 7.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -771.25K | -10.38M | -1.21M | 958.34K | 66.57K | 1.97M | 281K | -215K | 183K |
| Pretax Income | -15.78M | -36.03M | -55.76M | -45.13M | -24.68M | -18.07M | -22.59M | -19.02M | -11.98M |
| Pretax Margin % | -62.1% | -44.4% | -56.16% | -18.88% | -7.06% | -3.31% | -2.63% | -1.19% | -0.48% |
| Income Tax | -44.15K | 0 | 2.43K | 17.7K | -1.17M | -851K | -431K | -186K | -93K |
| Effective Tax Rate % | 1% | 0.99% | 1% | 1% | 0.95% | 0.95% | 0.98% | 0.99% | 0.99% |
| Net Income | -15.74M | -35.79M | -55.82M | -45.15M | -23.51M | -17.22M | -22.16M | -18.83M | -11.89M |
| Net Margin % | -61.92% | -44.11% | -56.22% | -18.89% | -6.73% | -3.16% | -2.58% | -1.17% | -0.47% |
| Net Income Growth % | - | -1.27% | -0.56% | 0.19% | 0.48% | 0.27% | -0.29% | 0.15% | 0.37% |
| Net Income (Continuing) | -15.78M | -36.03M | -55.77M | -45.15M | -23.51M | -17.22M | -22.16M | -18.83M | -11.89M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 400.42K | 604.05K | 635.61K | 635.61K | 635.61K | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.57 | -5.52 | -28.61 | -23.05 | -9.04 | -4.36 | -4.69 | -3.42 | -1.59 |
| EPS Growth % | - | -2.52% | -4.18% | 0.19% | 0.61% | 0.52% | -0.08% | 0.27% | 0.54% |
| EPS (Basic) | -1.57 | -5.52 | -28.61 | -23.05 | -9.04 | -4.36 | -4.69 | -3.42 | -1.59 |
| Diluted Shares Outstanding | 10.04M | 6.48M | 1.95M | 1.96M | 2.6M | 3.95M | 4.73M | 5.51M | 7.48M |
| Basic Shares Outstanding | 10.04M | 6.48M | 1.95M | 1.96M | 2.6M | 3.95M | 4.73M | 5.51M | 7.48M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 505.94K | 39.03M | 72.7M | 26.53M | 25.06M | 37.54M | 21.17M | 14.29M | 16.3M |
| Cash & Short-Term Investments | 416.34K | 37.17M | 68.56M | 24.06M | 22.63M | 34.69M | 17.71M | 10.33M | 11.97M |
| Cash Only | 416.34K | 13.22M | 7.6M | 13.56M | 4.24M | 34.69M | 17.71M | 10.33M | 3.45M |
| Short-Term Investments | 0 | 23.95M | 60.96M | 10.5M | 18.39M | 0 | 0 | 0 | 8.52M |
| Accounts Receivable | 24.71K | 103.21K | 267.6K | 496.14K | 270.55K | 438K | 401K | 717K | 1.37M |
| Days Sales Outstanding | 35.49 | 46.42 | 98.37 | 75.76 | 28.25 | 29.33 | 17.04 | 16.33 | 19.81 |
| Inventory | 48.47K | 327.79K | 1.95M | 911.17K | 876.44K | 1.36M | 1.98M | 2.16M | 1.68M |
| Days Inventory Outstanding | 142.99 | 230.73 | 1.23K | 287.46 | 184.11 | 358.68 | 446.31 | 281.17 | 161.62 |
| Other Current Assets | 16.42K | 856.89K | 1.92M | -20.18K | 0 | -572 | 1.08M | 1.09M | 1.29M |
| Total Non-Current Assets | 116.08K | 199.25K | 805.8K | 8.93M | 6.45M | 5.29M | 3.58M | 1.81M | 4.17M |
| Property, Plant & Equipment | 48.43K | 168.65K | 380.9K | 1.78M | 761.3K | 760K | 615K | 706K | 3.9M |
| Fixed Asset Turnover | 5.25x | 4.81x | 2.61x | 1.35x | 4.59x | 7.17x | 13.97x | 22.71x | 6.46x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 67.65K | 30.6K | 424.9K | 7.15M | 5.69M | 4.53M | 2.97M | 1.1M | 274K |
| Total Assets | 622.02K | 39.23M | 73.5M | 35.46M | 31.52M | 42.83M | 24.76M | 16.1M | 20.47M |
| Asset Turnover | 0.41x | 0.02x | 0.01x | 0.07x | 0.11x | 0.13x | 0.35x | 1.00x | 1.23x |
| Asset Growth % | - | 62.07% | 0.87% | -0.52% | -0.11% | 0.36% | -0.42% | -0.35% | 0.27% |
| Total Current Liabilities | 4.14M | 6.12M | 7.07M | 9.14M | 5.89M | 5.49M | 7.04M | 8.12M | 9.15M |
| Accounts Payable | 2.24M | 840.38K | 2.7M | 5.21M | 2.08M | 938K | 2.13M | 2.16M | 1.83M |
| Days Payables Outstanding | 6.61K | 591.55 | 1.7K | 1.64K | 436.67 | 247.2 | 480.87 | 281.56 | 176.18 |
| Short-Term Debt | 0 | 0 | 0 | 111.88K | 311.35K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 152K | 245K | 78K |
| Other Current Liabilities | 838.78K | 2.24M | 948.59K | 1.64M | 1.8M | 3.26M | 2.77M | 3.13M | 3.88M |
| Current Ratio | 0.12x | 6.38x | 10.28x | 2.90x | 4.26x | 6.84x | 3.01x | 1.76x | 1.78x |
| Quick Ratio | 0.11x | 6.33x | 10.00x | 2.80x | 4.11x | 6.60x | 2.72x | 1.49x | 1.60x |
| Cash Conversion Cycle | -6.43K | -314.4 | -374.33 | -1.28K | -224.31 | 140.81 | -17.52 | 15.94 | 5.25 |
| Total Non-Current Liabilities | 57.54M | 122.58M | 245.63K | 1.42M | 1.98M | 700K | 625K | 537K | 3.77M |
| Long-Term Debt | 3.67M | 0 | 0 | 0 | 1.1M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 1.42M | 885.33K | 700K | 625K | 537K | 3.77M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 53.87M | 122.58M | 245.63K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 61.68M | 128.7M | 7.32M | 10.56M | 7.87M | 6.18M | 7.67M | 8.66M | 12.93M |
| Total Debt | 3.67M | 0 | 0 | 2.02M | 2.83M | 761K | 699K | 626K | 4.14M |
| Net Debt | 3.25M | -13.22M | -7.6M | -11.55M | -1.41M | -33.93M | -17.01M | -9.71M | 686K |
| Debt / Equity | - | - | - | 0.08x | 0.12x | 0.02x | 0.04x | 0.08x | 0.55x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -19.46x | -3.60x | - | - | - | - | - | - | - |
| Total Equity | -61.05M | -89.47M | 66.19M | 24.9M | 23.64M | 36.65M | 17.09M | 7.44M | 7.54M |
| Equity Growth % | - | -0.47% | 1.74% | -0.62% | -0.05% | 0.55% | -0.53% | -0.56% | 0.01% |
| Book Value per Share | -6.08 | -13.81 | 33.93 | 12.71 | 9.09 | 9.29 | 3.61 | 1.35 | 1.01 |
| Total Shareholders' Equity | -61.45M | -90.07M | 65.55M | 24.26M | 23.01M | 36.65M | 17.09M | 7.44M | 7.54M |
| Common Stock | 30.91M | 40.18M | 29.45K | 29.84K | 45.56K | 5K | 5K | 6K | 7K |
| Retained Earnings | -100.71M | -152.93M | -38.33M | -83.48M | -106.99M | -124.21M | -146.37M | -165.2M | -177.09M |
| Treasury Stock | -8.13M | -22.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 214.01K | 80.21K | 60.84K | -41.3K | -251.47K | 13K | -69K | -64K | 114K |
| Minority Interest | 400.42K | 604.05K | 635.61K | 635.61K | 635.61K | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -13.23M | -25.33M | -47.11M | -45.07M | -20.05M | -13.63M | -16.64M | -14.67M | -6.95M |
| Operating CF Margin % | -52.04% | -31.21% | -47.44% | -18.85% | -5.74% | -2.5% | -1.94% | -0.92% | -0.28% |
| Operating CF Growth % | - | -0.92% | -0.86% | 0.04% | 0.56% | 0.32% | -0.22% | 0.12% | 0.53% |
| Net Income | -15.78M | -36.03M | -55.77M | -45.15M | -23.51M | -17.22M | -22.16M | -18.83M | -11.89M |
| Depreciation & Amortization | 53.42K | 32.31K | 66.66K | 249.58K | 399.24K | 382K | 548K | 1.02M | 1.26M |
| Stock-Based Compensation | 142.58K | 462.33K | 7.6M | 3.9M | 3.27M | 3.3M | 2.68M | 1.7M | 1.87M |
| Deferred Taxes | 2.47K | -513.61K | 1.37M | -530.1K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 536.89K | 11.43M | -95.62K | -963.82K | 1.55M | -1.72M | 244K | 628K | 51K |
| Working Capital Changes | 1.82M | -711.61K | -289.09K | -2.57M | -1.76M | 1.63M | 2.04M | 815K | 1.76M |
| Change in Receivables | 75.11K | -78.5K | -164.39K | -228.54K | 225.59K | -217K | 37K | -262K | -710K |
| Change in Inventory | 1.01K | -279.32K | -1.62M | -4.96M | 735.64K | 371K | 296K | 96K | 713K |
| Change in Payables | 1.74M | -304.95K | 1.56M | 2.8M | -1.58M | 464K | 1.19M | 35K | 1.05M |
| Cash from Investing | 0 | -24.12M | -36.83M | 50.97M | -7.96M | 18.22M | 0 | -206K | -8.52M |
| Capital Expenditures | 0 | -152.53K | -278.92K | -69.67K | 0 | 0 | 0 | -206K | 0 |
| CapEx % of Revenue | - | 0.19% | 0.28% | 0.03% | - | - | - | 0.01% | - |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -23.97M | -36.55M | 51.04M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 9.27M | 62.49M | 78.33M | 160.84K | 18.9M | 25.68M | 0 | 7.49M | 8.44M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | -3.63B | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | 35.52K | 45.34M | 0 | 48.97K | 0 | 0 | 0 | -657K | 139K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -13.23M | -25.48M | -47.39M | -45.14M | -20.05M | -13.63M | -16.64M | -14.87M | -6.95M |
| FCF Margin % | -52.04% | -31.4% | -47.73% | -18.88% | -5.74% | -2.5% | -1.94% | -0.93% | -0.28% |
| FCF Growth % | - | -0.93% | -0.86% | 0.05% | 0.56% | 0.32% | -0.22% | 0.11% | 0.53% |
| FCF per Share | -1.32 | -3.93 | -24.29 | -23.04 | -7.71 | -3.45 | -3.52 | -2.70 | -0.93 |
| FCF Conversion (FCF/Net Income) | 0.84x | 0.71x | 0.84x | 1.00x | 0.85x | 0.79x | 0.75x | 0.78x | 0.58x |
| Interest Paid | 0 | 0 | 0 | 3.46K | 12.89K | 10K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 45.64K | 29.54K | 3.77K | 39K | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -84.34% | -99.14% | -96.87% | -57.11% | -82.49% | -153.57% | -158.63% |
| Return on Invested Capital (ROIC) | - | - | -69.84% | -96.1% | -104.33% | -120.49% | -1228.46% | - | -305.73% |
| Gross Margin | 51.31% | 36.1% | 41.72% | 51.6% | 50.3% | 74.59% | 81.19% | 82.51% | 84.97% |
| Net Margin | -6192.44% | -4410.88% | -5621.66% | -1888.81% | -672.55% | -315.87% | -257.94% | -117.49% | -47.2% |
| Debt / Equity | - | - | - | 0.08x | 0.12x | 0.02x | 0.04x | 0.08x | 0.55x |
| Interest Coverage | -19.46x | -3.60x | - | - | - | - | - | - | - |
| FCF Conversion | 0.84x | 0.71x | 0.84x | 1.00x | 0.85x | 0.79x | 0.75x | 0.78x | 0.58x |
| Revenue Growth | - | 219.3% | 22.37% | 140.72% | 46.25% | 55.93% | 57.62% | 86.57% | 57.09% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 619.77K | 1.61M | 2.37M | 3.94M | 6.97M | 14.21M | 23.33M |
| UNITED STATES Growth | - | 159.10% | 47.88% | 65.91% | 77.01% | 103.74% | 64.21% |
| Other Countries | - | - | - | - | - | 148K | 119K |
| Other Countries Growth | - | - | - | - | - | - | -19.59% |
| JAPAN | - | - | - | - | 139K | 102K | 65K |
| JAPAN Growth | - | - | - | - | - | -26.62% | -36.27% |
| Other | 19.31K | 16.41K | 16.01K | 138.36K | 183K | - | - |
| Other Growth | - | -15.00% | -2.42% | 763.97% | 32.27% | - | - |
| GERMANY | 53.78K | 102.43K | 53.92K | 28.99K | - | - | - |
| GERMANY Growth | - | 90.44% | -47.35% | -46.23% | - | - | - |
electroCore, Inc. (ECOR) reported $29.8M in revenue for fiscal year 2024. This represents a 11640% increase from $0.3M in 2016.
electroCore, Inc. (ECOR) grew revenue by 57.1% over the past year. This is strong growth.
electroCore, Inc. (ECOR) reported a net loss of $14.2M for fiscal year 2024.
electroCore, Inc. (ECOR) has a return on equity (ROE) of -158.6%. Negative ROE indicates the company is unprofitable.
electroCore, Inc. (ECOR) had negative free cash flow of $8.0M in fiscal year 2024, likely due to heavy capital investments.